{"id":227763,"date":"2023-06-04T06:44:01","date_gmt":"2023-06-04T06:44:01","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=227763"},"modified":"2023-06-04T06:44:01","modified_gmt":"2023-06-04T06:44:01","slug":"comt-inhibitors","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/","title":{"rendered":"Comt inhibitors"},"content":{"rendered":"<p>Catechol-omethyl transferase (COMT) inhibitors are a class of drugs that hinder the activity of an enzyme responsible for the degradation of dopamine. By impeding the function of this enzyme, COMT inhibitors help maintain higher levels of dopamine in the body. Two notable examples of COMT inhibitors are entacapone and tolcapone, which have been utilized in the treatment of various conditions. These medications effectively counteract the breakdown of dopamine, leading to enhanced dopamine availability and potentially beneficial outcomes for individuals experiencing dopamine-related disorders.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Catechol-omethyl transferase (COMT) inhibitors are a class of drugs that hinder the activity of an enzyme responsible for the degradation of dopamine. By impeding the function of this enzyme, COMT inhibitors help maintain higher levels of dopamine in the body. Two notable examples of COMT inhibitors are entacapone and tolcapone, which have been utilized in [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-227763","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Comt inhibitors - Definition of Comt inhibitors<\/title>\n<meta name=\"description\" content=\"Catechol-omethyl transferase (COMT) inhibitors are a class of drugs that hinder the activity of an enzyme responsible for the degradation of dopamine. By impeding the function of this enzyme, COMT inhibitors help maintain higher levels of dopamine in the body. Two notable examples of COMT inhibitors are entacapone and tolcapone, which have been utilized in the treatment of various conditions. These medications effectively counteract the breakdown of dopamine, leading to enhanced dopamine availability and potentially beneficial outcomes for individuals experiencing dopamine-related disorders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Comt inhibitors - Definition of Comt inhibitors\" \/>\n<meta property=\"og:description\" content=\"Catechol-omethyl transferase (COMT) inhibitors are a class of drugs that hinder the activity of an enzyme responsible for the degradation of dopamine. By impeding the function of this enzyme, COMT inhibitors help maintain higher levels of dopamine in the body. Two notable examples of COMT inhibitors are entacapone and tolcapone, which have been utilized in the treatment of various conditions. These medications effectively counteract the breakdown of dopamine, leading to enhanced dopamine availability and potentially beneficial outcomes for individuals experiencing dopamine-related disorders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-04T06:44:01+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/\",\"name\":\"Comt inhibitors - Definition of Comt inhibitors\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2023-06-04T06:44:01+00:00\",\"dateModified\":\"2023-06-04T06:44:01+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Catechol-omethyl transferase (COMT) inhibitors are a class of drugs that hinder the activity of an enzyme responsible for the degradation of dopamine. By impeding the function of this enzyme, COMT inhibitors help maintain higher levels of dopamine in the body. Two notable examples of COMT inhibitors are entacapone and tolcapone, which have been utilized in the treatment of various conditions. These medications effectively counteract the breakdown of dopamine, leading to enhanced dopamine availability and potentially beneficial outcomes for individuals experiencing dopamine-related disorders.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Comt inhibitors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Comt inhibitors - Definition of Comt inhibitors","description":"Catechol-omethyl transferase (COMT) inhibitors are a class of drugs that hinder the activity of an enzyme responsible for the degradation of dopamine. By impeding the function of this enzyme, COMT inhibitors help maintain higher levels of dopamine in the body. Two notable examples of COMT inhibitors are entacapone and tolcapone, which have been utilized in the treatment of various conditions. These medications effectively counteract the breakdown of dopamine, leading to enhanced dopamine availability and potentially beneficial outcomes for individuals experiencing dopamine-related disorders.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/","og_locale":"en_US","og_type":"article","og_title":"Comt inhibitors - Definition of Comt inhibitors","og_description":"Catechol-omethyl transferase (COMT) inhibitors are a class of drugs that hinder the activity of an enzyme responsible for the degradation of dopamine. By impeding the function of this enzyme, COMT inhibitors help maintain higher levels of dopamine in the body. Two notable examples of COMT inhibitors are entacapone and tolcapone, which have been utilized in the treatment of various conditions. These medications effectively counteract the breakdown of dopamine, leading to enhanced dopamine availability and potentially beneficial outcomes for individuals experiencing dopamine-related disorders.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/","og_site_name":"Glossary","article_published_time":"2023-06-04T06:44:01+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/","name":"Comt inhibitors - Definition of Comt inhibitors","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2023-06-04T06:44:01+00:00","dateModified":"2023-06-04T06:44:01+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Catechol-omethyl transferase (COMT) inhibitors are a class of drugs that hinder the activity of an enzyme responsible for the degradation of dopamine. By impeding the function of this enzyme, COMT inhibitors help maintain higher levels of dopamine in the body. Two notable examples of COMT inhibitors are entacapone and tolcapone, which have been utilized in the treatment of various conditions. These medications effectively counteract the breakdown of dopamine, leading to enhanced dopamine availability and potentially beneficial outcomes for individuals experiencing dopamine-related disorders.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/comt-inhibitors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Comt inhibitors"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/227763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=227763"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/227763\/revisions"}],"predecessor-version":[{"id":227764,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/227763\/revisions\/227764"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=227763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=227763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=227763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}